Root Financial Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15M Buy
1,796
+147
+9% +$150K 0.08% 73
2026
Q1
$1.52M Sell
1,649
-1,304
-44% -$1.32M 0.07% 77
2025
Q4
$3.17M Buy
2,953
+137
+5% +$131K 0.16% 43
2025
Q3
$2.15M Sell
2,816
-203
-7% -$151K 0.13% 48
2025
Q2
$2.35M Buy
3,019
+631
+26% +$490K 0.23% 41
2025
Q1
$1.97M Sell
2,388
-37
-2% -$30.8K 0.21% 36
2024
Q4
$1.87M Buy
2,425
+233
+11% +$193K 0.23% 33
2024
Q3
$1.94M Buy
2,192
+1,730
+374% +$1.56M 0.31% 28
2024
Q2
$418K Buy
462
+40
+9% +$32K 0.1% 76
2024
Q1
$329K Buy
+422
New +$300K 0.1% 72

Other funds holding LLY

Root Financial Partners's LLY Position: Q2 2026 in Review

Root Financial Partners increased its Eli Lilly (LLY) stake by 8.9% in Q2 2026, buying an estimated $150K and bringing the position to 1,796 shares worth $2.15M. The position accounts for 0.08% of the portfolio, ranked #73.

Root Financial Partners first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.17M in Q4 2025. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Root Financial Partners held 1,796 shares of Eli Lilly worth $2.15M as of Q2 2026.
  • Root Financial Partners bought 147 Eli Lilly shares in Q2 2026, an estimated $150K.
  • Eli Lilly made up 0.08% of Root Financial Partners's portfolio in Q2 2026, its #73 holding.
  • Root Financial Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Root Financial Partners's Eli Lilly position peaked at $3.17M in Q4 2025.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.